GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Samsung Pharmaceutical Co Ltd (XKRX:001360) » Definitions » Cyclically Adjusted Book per Share

Samsung Pharmaceutical Co (XKRX:001360) Cyclically Adjusted Book per Share : ₩0.00 (As of Mar. 2025)


View and export this data going back to 1975. Start your Free Trial

What is Samsung Pharmaceutical Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Samsung Pharmaceutical Co's adjusted book value per share for the three months ended in Mar. 2025 was ₩1,520.436. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩0.00 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Samsung Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was -0.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -3.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -5.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Samsung Pharmaceutical Co was -3.80% per year. The lowest was -7.90% per year. And the median was -6.15% per year.

As of today (2025-05-22), Samsung Pharmaceutical Co's current stock price is ₩1472.00. Samsung Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ₩0.00. Samsung Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Samsung Pharmaceutical Co was 4.68. The lowest was 0.68. And the median was 1.23.


Samsung Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Samsung Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsung Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Samsung Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,244.26 2,096.55 1,965.30 1,870.54 1,867.14

Samsung Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,883.49 1,860.72 1,858.73 1,867.14 -

Competitive Comparison of Samsung Pharmaceutical Co's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Samsung Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Samsung Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Samsung Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Samsung Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


;
;

Samsung Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Samsung Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=1520.436/122.5900*122.5900
=1,520.436

Current CPI (Mar. 2025) = 122.5900.

Samsung Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201506 1,106.005 100.051 1,355.164
201509 1,072.970 100.111 1,313.898
201512 1,292.717 100.220 1,581.257
201603 1,279.373 100.561 1,559.635
201606 1,442.584 100.791 1,754.590
201609 1,950.820 101.461 2,357.069
201612 1,713.669 101.561 2,068.491
201703 1,659.202 102.851 1,977.641
201706 1,631.166 102.611 1,948.758
201709 1,580.221 103.491 1,871.856
201712 1,871.867 102.991 2,228.084
201803 1,926.050 104.101 2,268.133
201806 2,108.529 104.130 2,482.319
201809 2,120.468 105.651 2,460.454
201812 2,041.318 104.351 2,398.117
201903 2,123.615 104.491 2,491.451
201906 2,161.378 104.881 2,526.326
201909 2,064.317 105.200 2,405.550
201912 2,185.940 105.121 2,549.192
202003 2,051.652 105.354 2,387.299
202006 1,941.993 105.112 2,264.911
202009 1,958.657 106.198 2,260.990
202012 1,788.321 105.765 2,072.798
202103 2,028.793 107.357 2,316.656
202106 1,978.945 107.579 2,255.085
202109 1,888.765 108.759 2,128.957
202112 1,710.786 109.676 1,912.219
202203 1,690.623 111.848 1,852.992
202206 1,576.670 114.072 1,694.399
202209 1,525.370 114.715 1,630.080
202212 1,379.026 115.179 1,467.755
202303 1,341.296 116.507 1,411.322
202306 1,293.379 117.182 1,353.068
202309 1,209.462 118.964 1,246.330
202312 1,042.901 118.837 1,075.836
202403 1,194.658 120.123 1,219.191
202406 1,085.269 120.007 1,108.625
202409 1,279.989 120.861 1,298.298
202412 1,124.685 121.135 1,138.192
202503 1,520.436 122.590 1,520.436

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Samsung Pharmaceutical Co  (XKRX:001360) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Samsung Pharmaceutical Co was 4.68. The lowest was 0.68. And the median was 1.23.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Samsung Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Samsung Pharmaceutical Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Samsung Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
35 Jeyakgongdan 2-gil, Hyangnam-eup, Hwaseong, KOR, 445-746
Samsung Pharmaceutical Co Ltd is a South Korea based company engages in the manufacturing, supply, and distribution of pharmaceutical products. The company offers over the counter (OTC) drugs, prescription drugs, energy drinks, insecticides, and healthcare food items.

Samsung Pharmaceutical Co Headlines

No Headlines